Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.
about
Human β-cell proliferation and intracellular signaling: part 3Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonistsThe required beta cell research for improving treatment of type 2 diabetesTranslational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granulesEuroDia: a beta-cell gene expression resourceContribution of Intronic miR-338-3p and Its Hosting Gene AATK to Compensatory β-Cell Mass Expansion.Exendin-4 Protects MIN6 Cells from t-BHP-Induced Apoptosis via IRE1-JNK-Caspase-3 SignalingGlutamine stimulates biosynthesis and secretion of insulin-like growth factor 2 (IGF2), an autocrine regulator of beta cell mass and function.Incretin-based therapies in prediabetes: Current evidence and future perspectivesGenome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell massCyclic AMP is both a pro-apoptotic and anti-apoptotic second messengerClic4, a novel protein that sensitizes β-cells to apoptosisGluco-incretins regulate beta-cell glucose competence by epigenetic silencing of Fxyd3 expressionHepatic glucose sensing is required to preserve β cell glucose competence.A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function.Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.Systematic Design of Trypsin Cleavage Site Mutated Exendin4-Cysteine 1, an Orally Bioavailable Glucagon-Like Peptide-1 Receptor Agonist.Gastrointestinal hormones and the regulation of β-cell mass.IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.New insights concerning the molecular basis for defective glucoregulation in soluble adenylyl cyclase knockout miceInsulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells.GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice.Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells.GIP: no longer the neglected incretin twin?Pharmacological inhibition of diacylglycerol acyltransferase-1 and insights into postprandial gut peptide secretion.GLP-1 and IGF-I levels are elevated in late infancy in low birth weight infants, independently of GLP-1 receptor polymorphisms and neonatal nutrition.Equine glucagon-like peptide-1 receptor physiology.Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB.Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice.
P2860
Q26821954-DA855F46-1E3A-4E2A-9411-9DDE7DA306EFQ26823085-7D1BAB58-0A86-4885-AB9E-105D0F8B01F7Q26851305-D4F107F9-7970-4D38-93CB-162D0BA8782FQ27022700-DF433423-B69F-4197-B96B-86C9EB59E691Q28748737-2D5E0D75-BA0A-4140-A457-9B141B2EDF1DQ33631728-9D049929-9C40-4B56-90C2-205527DE0495Q34240080-4A10E591-2BB2-43E0-ACB1-6AE890C4133FQ34509707-8B4898B5-EEC6-40B7-92D9-970F207FCFA6Q34699191-4005EB22-57C9-477E-A125-BC62428C6729Q34762509-FEA9E0C2-6E8E-4FAA-8B92-1A9949B86DA1Q35055522-CAC52BBB-D208-484B-AFA1-5E8B9EF07DAFQ35074567-B2BBB74A-467A-4D2B-8DFC-099985A56A09Q35163097-6B690742-3D43-476D-879F-67EAB50A9FC2Q35212540-F070CB9B-F4F2-434A-A274-7EA9CDBCB460Q36733443-748BF81D-ACAE-4D21-BEFA-93D938BF23A9Q36964030-7F4517E6-D8FA-4DEE-9ADC-CAE8A6063166Q37635255-130C31B3-7FBF-43FC-992F-E0441B05F120Q37729181-7FF60EF8-22A9-4017-B730-3D37E8404AEAQ37805600-996C10AB-A232-4039-AE1D-E0A26AFF56F0Q37829755-F0057DEB-87A1-4900-AC40-69CF01E2E8A8Q38224884-FAB2C64E-0526-4D77-BE49-0FAC5B60478FQ38646665-008ED9A9-9133-4340-B59D-9841050FA709Q38773675-3992DC5D-0B3E-4AF3-8355-B8B6D6CB1A50Q41530980-103033FF-B7CD-48C7-A912-C0BFAD1DB402Q42906338-FD76B39F-C1BF-4762-899A-F7F54B10E10DQ47156353-7CD616D7-DE71-49A2-9B3F-B3E73A7324DFQ47178594-00597D57-CDA8-4550-9D71-9560A9AC0689Q48500262-E6F4DB43-83EA-42D4-8842-18D579BE16F5Q51107548-31ABFE44-8310-4469-A652-DEFE7CCD9FF0Q53207032-0A3AF02F-BCD1-487F-AB03-C188F8E90DC5
P2860
Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Glucagon-like peptide-1 increa ...... factor-1 receptor expression.
@ast
Glucagon-like peptide-1 increa ...... factor-1 receptor expression.
@en
type
label
Glucagon-like peptide-1 increa ...... factor-1 receptor expression.
@ast
Glucagon-like peptide-1 increa ...... factor-1 receptor expression.
@en
prefLabel
Glucagon-like peptide-1 increa ...... factor-1 receptor expression.
@ast
Glucagon-like peptide-1 increa ...... factor-1 receptor expression.
@en
P2093
P2860
P356
P1476
Glucagon-like peptide-1 increa ...... factor-1 receptor expression.
@en
P2093
Bernard Thorens
Dan Kawamori
Honey Modi
Magali Joffraud
Marion Cornu
Rohit N Kulkarni
P2860
P304
10538-10545
P356
10.1074/JBC.M109.091116
P407
P577
2010-02-09T00:00:00Z